AM
Therapeutic Areas
Mapi Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Glatiramer Acetate Depot | Relapsing‑remitting Multiple Sclerosis | Phase 3 |
| Pregabalin ER | Neuropathic Pain / Epilepsy | Preclinical |
| GLP‑1 Peptide Long‑Acting Injectable | Metabolic Disease | Preclinical |
| Buspirone ER | Anxiety | Preclinical |
| Paliperidone Depot | Schizophrenia | Preclinical |
| Aripiprazole Depot | Schizophrenia | Preclinical |